Company · CIK 0001649989 · SIC 2836 — Biological Products, (No Diagnostic Substances) · Nasdaq
Outlook Therapeutics, Inc. · OTLK
Insider activity reported against this company. All insider holders · On EDGAR ↗
Reported at this company — common stock
No reported common-stock activity in this period.
Reported at this company — derivatives (options, RSUs, warrants)
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 1, 2026 AForm 4 → | Sep 2, 4:32 pm EDT | Kevin Michael LundquistChief Financial Officer | 500,000 | — | — | 500,000 | — |